CLINICAL_TRIALS
trial_result
· 2018-10-25
Clinical Trial Update: A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis [Phase 2]
Summary
Phase 2 trial evaluating efficacy and safety of 122-0551 in subjects with plaque psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Therapeutics, Inc. | Conditions: Psoriasis, Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2018-10-25